Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > new corp slide deck

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Oct 25, 2023 12:48pm

203 Views

Post# 35700391

RE:new corp slide deck

Thanks for the link. Slide 16 is interesting.

If the slide is right, we have been comparing our 15 month durable CRR rates with our competitor's 12 month durable CRR rates. We're doing even better than we thought !

approved	patients	initial CRR	12 mo CRR	15 mo CRR	Safety
Valrubicin	90	21%	7.7%	N/A	SAEs
Keytruda	96	40%	18.9%	N/A	SAEs
Adstiladrin	98	51%	23.5%	n/A	SAEs

in progress
Ruvidar	62	65%	36%	33%	no SAEs

DJDawg wrote:
https://theralase.com/corporate-presentation/

Looks like mostly data that we know.

One new nugget is that have treated 62 patients. So another three from last update.